The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke
Open accessAbstract
Background and Purpose —The mechanisms for clinical deterioration in patients with ischemic stroke are not completely understood. Several proinflammatory cytokines are released early after the onset of brain ischemia, but it is unknown whether inflammation predisposes to neurological deterioration. We assessed the implication of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in early neurological worsening in ischemic stroke. Methods —Two hundred thirty-one patients consecutively admitted with first-ever ischemic cerebral infarction within the first 24 hours from onset were included. Neurological worsening was defined when the Canadian Stroke Scale (CSS) score fell at least 1 point during the first 48 hours after admission. IL-6 and TNF-α were determined in plasma and cerebrospinal fluid (CSF; n=81) obtained on admission. Results —Eighty-three patients (35.9%) deteriorated within the first 48 hours. IL-6 in plasma (>21.5 pg/mL; OR 37.7, CI 11.9 to 118.8) or in CSF (>6.3 pg/mL; OR 13.1, CI 2.2 to 77.3) were independent factors for early clinical worsening, with multiple logistic regression. The association was statistically significant in all ischemic stroke subtypes as well as in subjects with cortical or subcortical infarctions. IL-6 in plasma was highly correlated with body temperature, glucose, fibrinogen, and infarct volume. CSF and plasma concentrations of TNF-α were also higher in patients who deteriorated, but the differences observed did not remain significant on multivariate analysis. Conclusions —In addition to participating in the acute-phase response that follows focal cerebral ischemia, IL-6 levels on admission are associated with early clinical deterioration. The association between IL-6 and early neurological worsening prevails without regard to the initial size, topography, or mechanism of the ischemic infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Tumor Necrosis Factor-α: A Mediator of Focal Ischemic Brain Injury
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., & Feuerstein, G. Z. (1997) · Stroke · doi:10.1161/01.str.28.6.1233 · Cited by 863
del Zoppo, G. J., Schmid-Schönbein, G. W., Mori, E., Copeland, B. R., & Chang, C. M. (1991) · Stroke · doi:10.1161/01.str.22.10.1276 · Cited by 765
Kochanek, P. M., & Hallenbeck, J. M. (1992) · Stroke · doi:10.1161/01.str.23.9.1367 · Cited by 615
Nawroth, P. P., Handley, D. A., Esmon, C. T., & Stern, D. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3460 · Cited by 582
Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats
Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., & Kogure, K. (1995) · Stroke · doi:10.1161/01.str.26.4.676 · Cited by 572
Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in Stroke
Tarkowski, E., Rosengren, L., Blomstrand, C., Wikkelsö, C., Jensen, C., Ekholm, S., & Tarkowski, A. (1995) · Stroke · doi:10.1161/01.str.26.8.1393 · Cited by 383
The Canadian Neurological Scale: a preliminary study in acute stroke.
Côté, R., Hachinski, V. C., Shurvell, B. L., Norris, J. W., & Wolfson, C. (1986) · Stroke · doi:10.1161/01.str.17.4.731 · Cited by 341
Fassbender, K., Rossol, S., Kammer, T., Daffertshofer, M., Wirth, S., Dollman, M., & Hennerici, M. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90289-5 · Cited by 325
Effect of blood pressure and diabetes on stroke in progression
Jørgensen, H. S., Nakayama, H., Olsen, T. S., & Raaschou, H. O. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92757-x · Cited by 322
Progression of ischaemic stroke and excitotoxic aminoacids
Castillo, J., Dávalos, A., & Noya, M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)04453-4 · Cited by 320
Self-citationRecent Infection as a Risk Factor for Cerebrovascular Ischemia
Grau, A. J., Buggle, F., Heindl, S., Steichen-Wiehn, C., Banerjee, T., Maiwald, M., Rohlfs, M., Suhr, H., Fiehn, W., Becher, H., et al. (1995) · Stroke · doi:10.1161/01.str.26.3.373 · Cited by 250
Toni, D. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310040014 · Cited by 240
Interleukin‐6 and interleukin‐1 receptor antagonist in acute stroke
Beamer, N. B., Coull, B. M., Clark, W. M., Hazel, J. S., & Silberger, J. R. (1995) · Annals of Neurology · doi:10.1002/ana.410370614 · Cited by 231
Intrathecal release of pro- and anti-inflammatory cytokines during stroke
TARKOWSKI, E., ROSENGREN, L., BLOMSTRAND, C., WIKKELSÖ, C., JENSEN, C., EKHOLM, S., & TARKOWSKI, A. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1997.4621483.x · Cited by 225
Deteriorating ischemic stroke: Risk factors and prognosis
Dávalos, A., Cendra, E., Teruel, J., Martinez, M., & Genís, D. (1990) · Neurology · doi:10.1212/wnl.40.12.1865 · Cited by 223
Self-citationIncreased Cytokine Release from Peripheral Blood Cells after Acute Stroke
Ferrarese, C., Mascarucci, P., Zoia, C., Cavarretta, R., Frigo, M., Begni, B., Sarinella, F., Frattola, L., & De Simoni, M. G. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199909000-00008 · Cited by 209
Kim, J. S., Yoon, S. S., Kim, Y. H., & Ryu, J. S. (1996) · Stroke · doi:10.1161/01.str.27.9.1553 · Cited by 197
Interleukin-6 is the Major Regulator of Acute Phase Protein Synthesis in Rat and Man
CASTELL, J. V., DAVID, M., KLAPPROTH, J., HEINRICH, P. C., ANDUS, T., GEIGER, T., GÓMEZ-LECHÓN, M., HIRANO, T., & KISHIMOTO, T. (1989) · Advances in Immunopharmacology · doi:10.1016/b978-0-08-036149-9.50026-9 · Cited by 177
Interleukin‐6: The Major Regulator of Acute‐Phase Protein Synthesis in Man and Rat
Castell, J. V., Andus, T., KUNZ, D., & Heinrich, P. C. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24001.x · Cited by 136
Deteriorating Stroke: Diagnostic Criteria, Predictors, Mechanisms and Treatment
Castillo, J. (1999) · Cerebrovascular Diseases · doi:10.1159/000047548 · Cited by 106
Self-citationEarly Prediction of Stroke Severity: Role of the Erythrocyte Sedimentation Rate
Chamorro, Á., Vila, N., Ascaso, C., Saiz, A., Montalvo, J., Alonso, P. G. T., & TOLOSA, E. S. (1995) · Stroke · doi:10.1161/01.str.26.4.573 · Cited by 97
Self-citationDifferential regulation by cytokines of human astrocyte nitric oxide production
Hu, S., Sheng, W. S., Peterson, P. K., & Chao, C. C. (1995) · Glia · doi:10.1002/glia.440150412 · Cited by 90
Cytokine-induced inflammation and long-term stroke functional outcome
Vila, N., Filella, X., Deulofeu, R., Ascaso, C., Abellana, R. M., & Chamorro, Á. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00319-0 · Cited by 86
Self-citationIntrathecal Expression of Proteins Regulating Apoptosis in Acute Stroke
Tarkowski, E., Rosengren, L., Blomstrand, C., Jensen, C., EKHOLM, S. E., & Tarkowski, A. (1999) · Stroke · doi:10.1161/01.str.30.2.321 · Cited by 83
Cytokines and reperfusion injury
Clark, W. M. (1997) · Neurology · doi:10.1212/wnl.49.5_suppl_4.s10 · Cited by 57
Formulas for threshold computations
Robert, C., Vermont, J., Bosson, J., François, P., & Jacques Demongeot, A. (1991) · Computers and Biomedical Research · doi:10.1016/0010-4809(91)90037-w · Cited by 38
Cited by
Inflammatory mechanisms in ischemic stroke: therapeutic approaches
Lakhan, S. E., Kirchgessner, A., & Hofer, M. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-97 · Cited by 1,072
Central nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
Inflammatory Cytokines in Experimental and Human Stroke
Lambertsen, K. L., Biber, K., & Finsen, B. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.88 · Cited by 732
The immunology of acute stroke
Chamorro, Á., Meisel, A., Planas, A. M., Urra, X., van de Beek, D., & Veltkamp, R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.98 · Cited by 707
Metadata
- Authors
- Vila, N., Castillo, J., Dávalos, A., & Chamorro, A.
- Venue
- Stroke
- Published
- 2000-10
- Volume
- 31
- Issue
- 10
- Pages
- 2325-2329
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2132401640
- Cited by
- 675
- References
- 27
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.